News

Pharma companies will need to do more than rely on pharmacies' adjudication of claims

More engagement with pharma financial, marketing and supply-chain teams calls for easier access, says the company

Feds allege that Guaranteed Returns improperly withheld over $116 million in reimbursements from drug purchasers

New study identifies a category between branded and generic

Some state-level changes give an indication of what to prepare for

An 'expectations convergence' is building in how drug efficacy aligns with patient outcomes

Contracts with payers that contain terms based on outcomes can highlight a drug's value

More complex products and higher risk are changing the nature of pharmaceutical outsourcing

As rare diseases have emerged as a market opportunity for pharma over the past several years, industry practices are beginning to stabilize

Nonprofit seeks to raise profile of the value of industry-wide identity-authentication standards

No-see policies leave many physicians in the dark about formularies and medication benefits

Self-styled '156-year-old startup' aims to attract small-to-medium companies with outsourced commercialization services

The pervasiveness of e-prescribing allows for better analysis of adherence, says NEHI

HDMA's research arm studies biosimilar market dynamics

Cardinal Health works with Americares, and McKesson with World Vision, to deliver supplies

Tracking systems dominate product introductions

Largest independent specialty pharmacy rides specialty-pharma wave

Efforts to align drug wholesaling business with manufacturer services

West Pharma's electronic autoinjectors will connect with HealthPrize software

Company is part of limited distribution for a Lundbeck neurologic treatment

Muted reaction to revelations of the Physician's Sunshine Act

Agreement with KEW Group brings genetic screening and a pathway program

Thomson Reuters Bioworld report tracks biosimilar development

Payer trends dominate near-term outlook

New study suspects Indian manufacturers 'differentiate drug quality according to the destination of consumption'